Teva announces appointment of Prof Itzhak Krinsky
September 20, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Itzhak Krinsky, Teva
Teva has announced the appointment of Professor Itzhak Krinsky as chairman of Teva Japan and Teva South Korea and head …
Sanofi cleared in sales row
September 20, 2012Medical Communications, Sales and Marketing ABPI, CDF, Jevtana, PMCPA, Sanofi
Sanofi has been cleared of any wrongdoing after allegations that it had broken multiple clauses in the ABPI Code of …
Boehringer submits new lung cancer drug
September 20, 2012Research and Development, Sales and Marketing Boehringer, NSCLC, Roche, Tarceva, afatinib
Boehringer Ingelheim has filed its new lung cancer drug with the EMA. Afatinib is the latest targeted therapy for lung …
Sandra Peterson joins J&J’s executive committee
September 20, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing J&J, JJ, Sandra Peterson
Sandra Peterson will join Johnson & Johnson on 1 December as Group Worldwide chairman and member of the company’s executive …
Afinitor’s new UK indication launched
September 20, 2012Sales and Marketing Afinitor, CHMP, Novartis, breast cancer
Novartis’ cancer drug Afinitor has been made available in the UK for patients with the most common form of advanced …
RSA announces new Board members
September 20, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nick Stephens, RSA executive search
Life sciences executive search and interim management specialists RSA has announced the appointment of Nick Stephens as executive chairman, John …
Silence Therapeutics appoints chief medical adviser
September 19, 2012Business Services, Research and Development, Sales and Marketing Michael Khan, Silence Therapeutics
Silence Therapeutics has announced the appointment of Michael Khan to its board of directors as chief medical adviser. Dr Khan …
J&J sets up life science centres
September 19, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing J&J, JJ, R&D, innovation
Johnson & Johnson is to set up what it calls regional innovation centres in a bid to speed up the …
Steven Gillis to join Shire Board of directors
September 19, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire, Steven Gillis
Shire has announced that Dr Steven Gillis will join the Board of directors in October this year. On joining the …
Salmonson is new chair of CHMP
September 19, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CHMP, EMA, MPA, Salmonson
Dr Tomas Salmonson has been elected chair of the Committee for Medicinal Products for Human Use (CHMP) for a three-year …
Circassia appoints Stewart Sharpe as VP Commercial Operations
September 19, 2012Medical Communications, Research and Development, Sales and Marketing Circassia, Stewart Sharpe
Speciality biopharma firm Circassia has announced the appointment of Stewart Sharpe to the newly-created position of vice president, Commercial Operations. …
Two new appointments at Pharmalink Consulting
September 18, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kevin Webb, Lorcan Flanagan, Pharmalink
Regulatory affairs specialists Pharmalink Consulting has announced two new appointments. Lorcan Flanagan (pictured) joins as European Business Development manager and …
Boehringer says it is rolling out ‘fully disposable’ biomanufacturing
September 18, 2012Manufacturing and Production Boehringer, CMO, GMP, SUSs
Boehringer Ingelheim says it has developed a production platform for biopharmaceuticals that makes full use disposable technologies both upstream and …
API supply issues lead Lundbeck to drop cancer drug
September 18, 2012Manufacturing and Production Elspar, Lundbeck, Ovation
Danish firm Lundbeck has decided to discontinue supplies of its leukaemia drug Elspar from December after struggling to find a …
UK at centre of Eisai plans
September 18, 2012Research and Development, Sales and Marketing CNS, Cancer Drugs Fund, Eisai, Fycompa, Halaven
Diseases of the central nervous system (CNS) and cancer will be the main areas targeted by Japanese firm Eisai as …
Pfizer issues guide for medicines disposal
September 18, 2012Manufacturing and Production EPA, PRDA, Pfizer
Pfizer has published a guide for the safe disposal of medicines targeted at healthcare professionals and facilities in the US. …
Asia-Pacific – pharma’s new centre of gravity?
September 18, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Asia-Pacific, AstraZeneca
A high-growth region for the pharmaceutical industry, Asia-Pacific incorporates a vast geography with a $20 trillion economy, and is home …
New data for Pfizer arthritis pill
September 18, 2012Research and Development, Sales and Marketing JAK, Pfizer, RA, tofacitinib
Pfizer is to release more data for its investigational rheumatoid arthritis (RA) pill tofacitinib which it hopes will demonstrate its …
Helix Health appoints John Evans as UK commercial manager
September 18, 2012Medical Communications, Research and Development, Sales and Marketing Helix Health, John Evans
Healthcare IT provider Helix Health has recruited John Evans to the role of UK commercial manager to expand its UK …
SHL to Exhibit at 2012 PDA Event in Las Vegas – Inspiring Integration
September 18, 2012Manufacturing and Production auto injector, autoinjector, inspiring integration, pen injector, shl group
With the biopharmaceutical industry’s drug delivery landscape quickly adapting to the introduction of several biologics drugs in recent years, a …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
